Showing 1-9 of 9 results
St. Baldrick's Foreign Beneficiary
Funded: 01-01-2017 through 12-31-2017
Funding Type: Beneficiary Outside the U.S.
Institution Location: Hong Kong,
Institution: Children's Cancer Foundation

Through this partnership with the Children's Cancer Foundation, proceeds from St. Baldrick's head-shaving events in Hong Kong support life-saving childhood cancer research in Hong Kong. The St. Baldrick's Foundation is proud to partner with the Children's Cancer Foundation and has been doing so since 2008.

Children's Cancer Foundation Hong Kong
Funded: 01-01-2016 through 12-31-2016
Funding Type: Beneficiary Outside the U.S.
Institution Location: Hong Kong,
Institution: Children's Cancer Foundation

Through this partnership with the Children's Cancer Foundation, proceeds from St. Baldrick's head-shaving events in Hong Kong support life-saving childhood cancer research in Hong Kong. The St. Baldrick's Foundation is proud to partner with the Children's Cancer Foundation and has been doing so since 2008.

Children's Cancer Foundation Hong Kong
Funded: 01-01-2015 through 12-31-2015
Funding Type: Beneficiary Outside the U.S.
Institution Location: Hong Kong,
Institution: Children's Cancer Foundation

Through this partnership with the Children's Cancer Foundation, proceeds from St. Baldrick's head-shaving events in Hong Kong support life-saving childhood cancer research in Hong Kong. This grant has funded four projects. The first project is an extension of a previous grant. It aims to accurately measure treatment response by identifying and counting residual leukemia cells in patients following treatment, as a result to avoid under-or over-treatment in the future. The second project explored palliative care needs. Palliative care plays an important role in improving symptom control and psychosocial care for pediatric cancer patients and their families. However, there are no international guidelines specifically made for pediatric palliative care (PPC), with the exception of pain management. A local study is thus needed to explore how PPC can be improved and to identify the essential skills, facilities and services needed in the provision of such care in Hong Kong hospitals and community settings. The third project is a study of a large inter-group randomized trial on whether rituximab (antibody) can add benefit to the current chemotherapy regimen for children and adolescents with high risk B cell non-Hodgkin lymphoma. The fourth project explored cardiac toxicity. Cardiac toxicity is one of the most concerning side effects of anti-cancer therapy. The gain in life expectancy obtained with anti-cancer therapy can be compromised by increased morbidity and mortality associated with its cardiac complications. The field of ‘pediatric cardo-oncology’ has emerged as an essential discipline to provide cardiac specialist care to pediatric cancer patients. In this project multi-modality evaluation on cardiac function is used to monitor the cardiac function of children after cancer therapy.

Children's Cancer Foundation Hong Kong
Funded: 01-01-2014 through 12-31-2014
Funding Type: Beneficiary Outside the U.S.
Institution Location: Hong Kong,
Institution: Children's Cancer Foundation

Through this partnership with the Children's Cancer Foundation, proceeds from St. Baldrick's head-shaving events in Hong Kong support life-saving childhood cancer research in Hong Kong. One of the two projects funded by this grant is an extension of pervious grant and aims to accurately measure treatment response by counting residual leukemia cells in patients following treatment. The second project is an European clinical trial studying the effectiveness of using antibody treatment together with chemotherapy and surgery for patients with newly diagnosed neuroblastoma.

Children's Cancer Foundation Hong Kong
Funded: 01-01-2013 through 12-31-2013
Funding Type: Beneficiary Outside the U.S.
Institution Location: Hong Kong,
Institution: Children's Cancer Foundation

Through this partnership with the Children's Cancer Foundation, proceeds from St. Baldrick's head-shaving events in Hong Kong support life-saving childhood cancer research in Hong Kong. One of the two projects funded by this grant establishes a centralized molecular genetic and chromosome analysis testing service for the diagnosis of pediatric solid tumor cancers. The second is an extension of previous grant and aims to accurately measure treatment response by counting residual leukemia cells in patients following treatment.

Children's Cancer Foundation Hong Kong
Funded: 01-01-2012 through 12-31-2012
Funding Type: Beneficiary Outside the U.S.
Institution Location: Hong Kong,
Institution: Children's Cancer Foundation

Through this partnership with the Children's Cancer Foundation, proceeds from St. Baldrick's head-shaving events in Hong Kong support life-saving childhood cancer research in Hong Kong. The four projects funded by this grant have wide-ranging implications for the clinical and psychosocial treatment of childhood cancer patients in Hong Kong. Of the three clinical programs, two are directed at improving treatment for children with ALL. The first of these aims to accurately measure treatment response by identifying and counting residual leukemia cells to avoid under- or over-treatment. The second examines the role and behavior of the protein CD9, in reducing leukemia cells. The third clinical research project establishes a central registry for pediatric brain tumor patients. The fourth project investigates how a patients' level of hope and rumination style affects their psychological well-being and adjustment toward cancer treatment.

Children's Cancer Foundation Hong Kong
Funded: 01-01-2011 through 12-31-2011
Funding Type: Beneficiary Outside the U.S.
Institution Location: Hong Kong,
Institution: Children's Cancer Foundation

Through this partnership with the Children's Cancer Foundation, proceeds from St. Baldrick's head-shaving events in Hong Kong support life-saving childhood cancer research in Hong Kong. The five projects funded by this grant will assist doctors in Hong Kong to develop stem cell treatment strategies for neuroblastoma, minimize long term lung complications in bone marrow transplant recipients, measure the role of genetic abnormalities in higher relapse rates for acute lymphoblastic leukemia patients, understand the effect of anti-cancer drugs on kidney function, and design surveillance strategies to minimize respiratory tract infection in the hospital setting among febrile children with cancer.

Children's Cancer Foundation Hong Kong
Funded: 01-01-2010 through 12-31-2010
Funding Type: Beneficiary Outside the U.S.
Institution Location: Hong Kong,
Institution: Children's Cancer Foundation

Through this partnership with the Children's Cancer Foundation, proceeds from St. Baldrick's head-shaving events in Hong Kong support life-saving childhood cancer research in Hong Kong. The project supported by this grant is a multicenter clinical study testing the best treatment strategy for Chinese children with Acute Lymphoblastic Leukemia. It started from 2008 and completed at the end of 2012. All the hospitals treating children with cancer in Hong Kong participated in this study, and 12 other centers in mainland China also joined the study. They performed a special test on the patients to find any residual leukemia cells in the body after initial chemotherapy treatment in the first 3 months of treatment. The special tests included “flow cytometry for leukemia specific antigen’ and “Quantitative Polymerase Chain Reaction for leukemia DNA”.

Children's Cancer Foundation Hong Kong
Funded: 07-01-2008 through 12-31-2009
Funding Type: Beneficiary Outside the U.S.
Institution Location: Hong Kong,
Institution: Children's Cancer Foundation

Through this partnership with the Children's Cancer Foundation, proceeds from St. Baldrick's head-shaving events in Hong Kong support life-saving childhood cancer research in Hong Kong. The project supported by this grant is a multicenter clinical study testing the best treatment strategy for Chinese children with Acute Lymphoblastic Leukemia. It started from 2008 and completed at the end of 2012. All the hospitals treating children with cancer in Hong Kong participated in this study, and 12 other centers in mainland China also joined the study. They performed a special test on the patients to find any residual leukemia cells in the body after initial chemotherapy treatment in the first 3 months of treatment. The special tests included “flow cytometry for leukemia specific antigen’ and “Quantitative Polymerase Chain Reaction for leukemia DNA”.